Mark Oldakowski

CIK: 0001745566

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)6 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BNGO

Bionano Genomics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

BNGO
Bionano Genomics, Inc.
Aug 3, 2026
Award(A)
Stock Option (Right to Buy)
Direct
15K shares-
BNGO
Bionano Genomics, Inc.
Jun 3, 2026
Tax Payment(F)
Direct
27 shares at avg. $1.30$35.1
BNGO
Bionano Genomics, Inc.
Feb 17, 2026
Tax Payment(F)
Direct
20 shares at avg. $1.10$22
BNGO
Bionano Genomics, Inc.
Feb 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
27.7K shares-
BNGO
Bionano Genomics, Inc.
Sep 11, 2025
Tax Payment(F)
Direct
59 shares at avg. $4.06$239.54
BNGO
Bionano Genomics, Inc.
Jun 3, 2025
Tax Payment(F)
Direct
27 shares at avg. $3.69$99.63
BNGO
Bionano Genomics, Inc.
Mar 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
7K shares-
BNGO
Bionano Genomics, Inc.
Feb 15, 2025
Tax Payment(F)
Direct
20 shares at avg. $5.73$114.6
BNGO
Bionano Genomics, Inc.
Sep 11, 2024
Tax Payment(F)
Direct
3.6K shares at avg. $0.48$2K

		Type	Shares	Price		Ownership
Aug 3, 2026	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	15,000	-	-	Direct
Jun 3, 2026	BNGO Bionano Genomics, Inc.	Tax Payment(F)	27	$1.30	$35	Direct
Feb 17, 2026	BNGO Bionano Genomics, Inc.	Tax Payment(F)	20	$1.10	$22	Direct
Feb 2, 2026	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	27,737	-	-	Direct
Sep 11, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	59	$4.06	$240	Direct
Jun 3, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	27	$3.69	$100	Direct
Mar 14, 2025	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	6,966	-	-	Direct
Feb 15, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	20	$5.73	$115	Direct
Sep 11, 2024	BNGO Bionano Genomics, Inc.	Tax Payment(F)	3,568	$0.48	$1,713	Direct

1-9 of 9 transactions

About OLDAKOWSKI MARK

OLDAKOWSKI MARK (SEC CIK 0001745566) files insider reports with the SEC as Chief Operating Officer of Bionano Genomics, Inc. (BNGO).

Signal8 holds 11 ownership filings by OLDAKOWSKI MARK (1 Form 3, 10 Form 4), filed between Sep 13, 2024 and Aug 5, 2026. Those filings report 9 transactions, from Sep 11, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on OLDAKOWSKI MARK's filings is in SAN DIEGO, CA.

Recent filings by OLDAKOWSKI MARK

Aug 3, 2026: Grant or award of BNGO derivative securities (Form 4, code A).
Jun 3, 2026: Tax withholding of BNGO shares (Form 4, code F).
Feb 17, 2026: Tax withholding of BNGO shares (Form 4, code F).
Feb 2, 2026: Grant or award of BNGO derivative securities (Form 4, code A).
Sep 11, 2025: Tax withholding of BNGO shares (Form 4, code F).

Other insiders filing for Bionano Genomics, Inc. (BNGO)

Luderer Albert, Interim Chief Executive
Adamchak Mark, Principal Accounting Officer
Dixon Jonathan V., General Counsel
Hastie Alex Reid, Chief Scientific Officer
Chaubey Alka, CHIEF MEDICAL OFFICER
Rajkovic Aleksandar, Director

How to read Form 4 transaction codes